

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58498914 |
| 2 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.18834603 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.11814672 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.11814672 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.11814672 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.11814672 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.11814672 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.11814672 |
| 9 | oligosaccharide catabolic process (GO:0009313) | 4.01235140 |
| 10 | negative regulation of complement activation (GO:0045916) | 3.84473471 |
| 11 | glycosphingolipid catabolic process (GO:0046479) | 3.68445190 |
| 12 | negative regulation of protein activation cascade (GO:2000258) | 3.48691616 |
| 13 | growth hormone receptor signaling pathway (GO:0060396) | 3.39365444 |
| 14 | glycolipid catabolic process (GO:0019377) | 3.30716518 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.27168857 |
| 16 | macroautophagy (GO:0016236) | 3.26593907 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.14565632 |
| 18 | positive regulation of receptor recycling (GO:0001921) | 3.13761455 |
| 19 | ceramide catabolic process (GO:0046514) | 3.10534994 |
| 20 | protein targeting to lysosome (GO:0006622) | 3.03607886 |
| 21 | establishment of protein localization to vacuole (GO:0072666) | 3.03607886 |
| 22 | protein targeting to vacuole (GO:0006623) | 3.03607886 |
| 23 | keratan sulfate catabolic process (GO:0042340) | 3.03215080 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 2.99620138 |
| 25 | microglial cell activation (GO:0001774) | 2.94385696 |
| 26 | negative regulation of humoral immune response (GO:0002921) | 2.92063603 |
| 27 | cellular response to growth hormone stimulus (GO:0071378) | 2.89523315 |
| 28 | detection of external biotic stimulus (GO:0098581) | 2.88961321 |
| 29 | early endosome to late endosome transport (GO:0045022) | 2.81087744 |
| 30 | amino sugar catabolic process (GO:0046348) | 2.80557256 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 2.80221334 |
| 32 | cellular response to ethanol (GO:0071361) | 2.76723869 |
| 33 | I-kappaB phosphorylation (GO:0007252) | 2.76398365 |
| 34 | positive regulation of p38MAPK cascade (GO:1900745) | 2.75161617 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74615566 |
| 36 | response to host immune response (GO:0052572) | 2.74615566 |
| 37 | definitive hemopoiesis (GO:0060216) | 2.73177048 |
| 38 | regulation of macrophage chemotaxis (GO:0010758) | 2.71690879 |
| 39 | surfactant homeostasis (GO:0043129) | 2.67948069 |
| 40 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.67464132 |
| 41 | response to lipoprotein particle (GO:0055094) | 2.61175356 |
| 42 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.59878609 |
| 43 | response to muramyl dipeptide (GO:0032495) | 2.57355946 |
| 44 | response to host (GO:0075136) | 2.57090913 |
| 45 | response to host defenses (GO:0052200) | 2.57090913 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.57090913 |
| 47 | adhesion of symbiont to host (GO:0044406) | 2.54432982 |
| 48 | detection of other organism (GO:0098543) | 2.52129400 |
| 49 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.52005523 |
| 50 | negative regulation of lipid storage (GO:0010888) | 2.51949224 |
| 51 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.51939811 |
| 52 | regulation of mononuclear cell migration (GO:0071675) | 2.51884383 |
| 53 | import into cell (GO:0098657) | 2.51580400 |
| 54 | regulation of cholesterol storage (GO:0010885) | 2.51004602 |
| 55 | negative regulation of interleukin-17 production (GO:0032700) | 2.50352747 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 2.49570956 |
| 57 | virion attachment to host cell (GO:0019062) | 2.49570956 |
| 58 | response to thyroid hormone (GO:0097066) | 2.45179426 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 2.44968834 |
| 60 | neutrophil activation (GO:0042119) | 2.42967826 |
| 61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.40938041 |
| 62 | macrophage activation (GO:0042116) | 2.40627784 |
| 63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38245728 |
| 64 | cellular extravasation (GO:0045123) | 2.37809818 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35178082 |
| 66 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33652316 |
| 67 | neutrophil mediated immunity (GO:0002446) | 2.32418849 |
| 68 | lung lobe morphogenesis (GO:0060463) | 2.32396696 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 2.32386289 |
| 70 | cell adhesion mediated by integrin (GO:0033627) | 2.32365749 |
| 71 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.32312988 |
| 72 | angiotensin maturation (GO:0002003) | 2.32130999 |
| 73 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.31106018 |
| 74 | detection of biotic stimulus (GO:0009595) | 2.31089586 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.31055665 |
| 76 | barbed-end actin filament capping (GO:0051016) | 2.31002051 |
| 77 | T-helper 1 type immune response (GO:0042088) | 2.30528686 |
| 78 | phospholipid efflux (GO:0033700) | 2.30371023 |
| 79 | granulocyte activation (GO:0036230) | 2.28670798 |
| 80 | phagocytosis, recognition (GO:0006910) | 2.28091876 |
| 81 | toxin transport (GO:1901998) | 2.27873388 |
| 82 | lipoprotein transport (GO:0042953) | 2.27098948 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.26937741 |
| 84 | positive regulation of sterol transport (GO:0032373) | 2.26689010 |
| 85 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.24270399 |
| 86 | blood vessel maturation (GO:0001955) | 2.23516371 |
| 87 | hypotonic response (GO:0006971) | 2.22562835 |
| 88 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.22064597 |
| 89 | apoptotic cell clearance (GO:0043277) | 2.21781058 |
| 90 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.21423130 |
| 91 | regulation of monocyte chemotaxis (GO:0090025) | 2.21206175 |
| 92 | response to peptidoglycan (GO:0032494) | 2.21114316 |
| 93 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.20814050 |
| 94 | sphingolipid catabolic process (GO:0030149) | 2.20255492 |
| 95 | nerve growth factor signaling pathway (GO:0038180) | 2.20219515 |
| 96 | viral entry into host cell (GO:0046718) | 2.20063803 |
| 97 | membrane lipid catabolic process (GO:0046466) | 2.19663784 |
| 98 | superoxide anion generation (GO:0042554) | 2.19633152 |
| 99 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.19204166 |
| 100 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.18959120 |
| 101 | skin morphogenesis (GO:0043589) | 2.18590673 |
| 102 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.18090860 |
| 103 | lipid translocation (GO:0034204) | 2.17843715 |
| 104 | phospholipid translocation (GO:0045332) | 2.17843715 |
| 105 | positive regulation of interferon-beta production (GO:0032728) | 2.17797099 |
| 106 | negative regulation of granulocyte differentiation (GO:0030853) | 2.17678925 |
| 107 | positive regulation of vasculogenesis (GO:2001214) | 2.17086964 |
| 108 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.16618575 |
| 109 | response to fluid shear stress (GO:0034405) | 2.16270654 |
| 110 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.14820163 |
| 111 | positive regulation of leukocyte degranulation (GO:0043302) | 2.14672873 |
| 112 | phospholipid homeostasis (GO:0055091) | 2.14316943 |
| 113 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.13463772 |
| 114 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.13237659 |
| 115 | protein targeting to Golgi (GO:0000042) | 2.12923569 |
| 116 | protein localization to endosome (GO:0036010) | 2.12074099 |
| 117 | positive regulation of coagulation (GO:0050820) | 2.11371589 |
| 118 | intracellular lipid transport (GO:0032365) | 2.11167807 |
| 119 | lymph vessel development (GO:0001945) | 2.11056813 |
| 120 | ovulation from ovarian follicle (GO:0001542) | 2.10711237 |
| 121 | lung vasculature development (GO:0060426) | 2.10687929 |
| 122 | establishment of protein localization to Golgi (GO:0072600) | 2.10414451 |
| 123 | endothelium development (GO:0003158) | 2.10370174 |
| 124 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.09925893 |
| 125 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.09803353 |
| 126 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.09794770 |
| 127 | prostate gland growth (GO:0060736) | 2.08945286 |
| 128 | regulation of macrophage cytokine production (GO:0010935) | 2.08464093 |
| 129 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.08383534 |
| 130 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.08238331 |
| 131 | positive regulation of T cell chemotaxis (GO:0010820) | 2.07947915 |
| 132 | regulation of T cell chemotaxis (GO:0010819) | 2.07947915 |
| 133 | cholesterol efflux (GO:0033344) | 2.07091404 |
| 134 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.06409228 |
| 135 | protein carboxylation (GO:0018214) | 2.06409228 |
| 136 | myeloid cell activation involved in immune response (GO:0002275) | 2.06042773 |
| 137 | establishment of endothelial barrier (GO:0061028) | 2.04951877 |
| 138 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.04801667 |
| 139 | peptide catabolic process (GO:0043171) | 2.03971607 |
| 140 | regulation of vasculogenesis (GO:2001212) | 2.03537911 |
| 141 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.03256232 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.03256232 |
| 143 | glomerular filtration (GO:0003094) | 2.02244646 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.02219640 |
| 145 | response to type I interferon (GO:0034340) | 2.00627981 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.00389072 |
| 147 | phagocytosis, engulfment (GO:0006911) | 1.99764374 |
| 148 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 1.99094075 |
| 149 | interleukin-1-mediated signaling pathway (GO:0070498) | 1.98254520 |
| 150 | positive regulation of cholesterol efflux (GO:0010875) | 1.98252582 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 1.98177076 |
| 152 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 1.98101460 |
| 153 | iron ion import (GO:0097286) | 1.98023373 |
| 154 | respiratory burst (GO:0045730) | 1.97951739 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 1.96661067 |
| 156 | Notch signaling involved in heart development (GO:0061314) | 1.96561755 |
| 157 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 1.95913728 |
| 158 | cellular response to type I interferon (GO:0071357) | 1.94472982 |
| 159 | type I interferon signaling pathway (GO:0060337) | 1.94472982 |
| 160 | leukocyte tethering or rolling (GO:0050901) | 1.94193687 |
| 161 | positive regulation of cholesterol transport (GO:0032376) | 1.93614935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88400007 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36585476 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29763137 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83219430 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.79808378 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71658691 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.69012846 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43310245 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43229691 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37286899 |
| 11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.19404159 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15934958 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09693415 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05459861 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05380836 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04853573 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98421916 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.98040363 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96370047 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95467758 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92241418 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88688818 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85932036 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85546736 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84054197 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78827364 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78460209 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72641821 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71251203 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.70444577 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69671618 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68426257 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67689137 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67373090 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.62248511 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61731165 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59942232 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58657775 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56115152 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.55838178 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54676988 |
| 42 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47652145 |
| 43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46047325 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45851621 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42724221 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42433360 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41871834 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41871834 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38581203 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38210975 |
| 51 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35529804 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34889310 |
| 53 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34631789 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34160082 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34002845 |
| 56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33088953 |
| 57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.32454984 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32161797 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32120989 |
| 60 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.26366682 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26161634 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25872320 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25584892 |
| 64 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.25389910 |
| 65 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25357969 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24419641 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23447658 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23119169 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22934193 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21910173 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21642991 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21362538 |
| 73 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20895621 |
| 74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20852715 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20610894 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20193917 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18545627 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17863463 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17095790 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16660869 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16368657 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16222600 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16069346 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15740519 |
| 85 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15001018 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14875069 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14189901 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12718523 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12689098 |
| 90 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10374049 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09840256 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09296650 |
| 93 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08495480 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07757227 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07406765 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06136180 |
| 97 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05130485 |
| 98 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04757324 |
| 99 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04733239 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04726577 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04582892 |
| 102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03966016 |
| 103 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03814840 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03597774 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03469136 |
| 106 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03324302 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01980152 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01973880 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01141033 |
| 110 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00349347 |
| 111 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00111159 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99306499 |
| 113 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98323759 |
| 114 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98323759 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97121627 |
| 116 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.96795652 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96528212 |
| 118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95676673 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95274416 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94266240 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94082663 |
| 122 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.93776333 |
| 123 | MYB_26560356_Chip-Seq_TH2_Human | 0.92811510 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92797880 |
| 125 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92561307 |
| 126 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92151470 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91501202 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90977770 |
| 129 | MYB_26560356_Chip-Seq_TH1_Human | 0.90204308 |
| 130 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88819153 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88435210 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87796491 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87787908 |
| 134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85399574 |
| 135 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85189959 |
| 136 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84432260 |
| 137 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84342152 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81814216 |
| 139 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80952311 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.80756068 |
| 141 | MAF_26560356_Chip-Seq_TH1_Human | 0.80232829 |
| 142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80135191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 2.65860217 |
| 2 | MP0010368_abnormal_lymphatic_system | 2.53477472 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 2.50418151 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 2.48642845 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.48378017 |
| 6 | MP0001879_abnormal_lymphatic_vessel | 2.38368889 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.35552395 |
| 8 | MP0003724_increased_susceptibility_to | 2.29909287 |
| 9 | MP0003436_decreased_susceptibility_to | 2.10932700 |
| 10 | MP0002419_abnormal_innate_immunity | 1.96636559 |
| 11 | MP0003252_abnormal_bile_duct | 1.96127246 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 1.93431811 |
| 13 | MP0009278_abnormal_bone_marrow | 1.86641430 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 1.85210187 |
| 15 | MP0002254_reproductive_system_inflammat | 1.84162778 |
| 16 | MP0005275_abnormal_skin_tensile | 1.83534203 |
| 17 | MP0005360_urolithiasis | 1.83082679 |
| 18 | MP0003690_abnormal_glial_cell | 1.82033705 |
| 19 | MP0003303_peritoneal_inflammation | 1.81535538 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.80848074 |
| 21 | MP0002009_preneoplasia | 1.78237214 |
| 22 | MP0006082_CNS_inflammation | 1.77541517 |
| 23 | MP0003828_pulmonary_edema | 1.76619326 |
| 24 | MP0000604_amyloidosis | 1.73213359 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.70190291 |
| 26 | MP0003195_calcinosis | 1.68086291 |
| 27 | MP0001851_eye_inflammation | 1.65687449 |
| 28 | MP0005387_immune_system_phenotype | 1.64322287 |
| 29 | MP0001790_abnormal_immune_system | 1.64322287 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.56965673 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.55202864 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.54835920 |
| 33 | MP0005025_abnormal_response_to | 1.53820793 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.52247502 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.50903559 |
| 36 | MP0000685_abnormal_immune_system | 1.50643876 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.50102669 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.48047658 |
| 39 | MP0006054_spinal_hemorrhage | 1.47575755 |
| 40 | MP0009785_altered_susceptibility_to | 1.45845431 |
| 41 | MP0002928_abnormal_bile_duct | 1.43924029 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.41370440 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.40648452 |
| 44 | MP0009840_abnormal_foam_cell | 1.39120548 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.38071933 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.38071933 |
| 47 | MP0000767_abnormal_smooth_muscle | 1.35486242 |
| 48 | MP0004272_abnormal_basement_membrane | 1.33139128 |
| 49 | MP0003045_fibrosis | 1.32184444 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.29793139 |
| 51 | MP0004484_altered_response_of | 1.29656593 |
| 52 | MP0009764_decreased_sensitivity_to | 1.29631998 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.29506550 |
| 54 | MP0001800_abnormal_humoral_immune | 1.29097396 |
| 55 | MP0003448_altered_tumor_morphology | 1.27993975 |
| 56 | MP0002006_tumorigenesis | 1.26153431 |
| 57 | MP0002723_abnormal_immune_serum | 1.25629556 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.23561661 |
| 59 | MP0005671_abnormal_response_to | 1.22959022 |
| 60 | MP0000427_abnormal_hair_cycle | 1.22569222 |
| 61 | MP0000343_altered_response_to | 1.22441865 |
| 62 | MP0000383_abnormal_hair_follicle | 1.21163846 |
| 63 | MP0004947_skin_inflammation | 1.19021111 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.19010931 |
| 65 | MP0002133_abnormal_respiratory_system | 1.17603579 |
| 66 | MP0005388_respiratory_system_phenotype | 1.17603579 |
| 67 | MP0001958_emphysema | 1.17517434 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.16841803 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.16627433 |
| 70 | MP0004147_increased_porphyrin_level | 1.16422294 |
| 71 | MP0008004_abnormal_stomach_pH | 1.16011503 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.14202715 |
| 73 | MP0005365_abnormal_bile_salt | 1.13264174 |
| 74 | MP0001819_abnormal_immune_cell | 1.12045963 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.11321688 |
| 76 | MP0008469_abnormal_protein_level | 1.10767778 |
| 77 | MP0003075_altered_response_to | 1.10459048 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.10385178 |
| 79 | MP0002420_abnormal_adaptive_immunity | 1.10247327 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 1.09797606 |
| 81 | MP0002405_respiratory_system_inflammati | 1.08412282 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.08064100 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.07612211 |
| 84 | MP0001853_heart_inflammation | 1.07596048 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.07581477 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06615603 |
| 87 | MP0005310_abnormal_salivary_gland | 1.06009373 |
| 88 | MP0004510_myositis | 1.05431113 |
| 89 | MP0001873_stomach_inflammation | 1.05097694 |
| 90 | MP0005164_abnormal_response_to | 1.04639780 |
| 91 | MP0003566_abnormal_cell_adhesion | 1.04074747 |
| 92 | MP0008260_abnormal_autophagy | 1.02872954 |
| 93 | MP0003943_abnormal_hepatobiliary_system | 1.02677314 |
| 94 | MP0000249_abnormal_blood_vessel | 1.01563641 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 1.01231001 |
| 96 | MP0004883_abnormal_blood_vessel | 1.00874959 |
| 97 | MP0005023_abnormal_wound_healing | 0.98603251 |
| 98 | MP0000920_abnormal_myelination | 0.94867959 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.94643466 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.94620216 |
| 101 | MP0003279_aneurysm | 0.92479761 |
| 102 | MP0000609_abnormal_liver_physiology | 0.92043979 |
| 103 | MP0009643_abnormal_urine_homeostasis | 0.91944409 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.91572392 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.90580605 |
| 106 | MP0010329_abnormal_lipoprotein_level | 0.90564287 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.89960499 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.88964108 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.87817537 |
| 110 | MP0002933_joint_inflammation | 0.87385187 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.87332845 |
| 112 | MP0009763_increased_sensitivity_to | 0.86784384 |
| 113 | MP0000371_diluted_coat_color | 0.86305620 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.85967483 |
| 115 | MP0005166_decreased_susceptibility_to | 0.85103973 |
| 116 | MP0001915_intracranial_hemorrhage | 0.84619097 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.83221608 |
| 118 | MP0004130_abnormal_muscle_cell | 0.83011115 |
| 119 | MP0000647_abnormal_sebaceous_gland | 0.82307084 |
| 120 | MP0000858_altered_metastatic_potential | 0.81478064 |
| 121 | MP0003091_abnormal_cell_migration | 0.81192609 |
| 122 | MP0005165_increased_susceptibility_to | 0.80841786 |
| 123 | MP0005409_darkened_coat_color | 0.80253951 |
| 124 | MP0005174_abnormal_tail_pigmentation | 0.80033859 |
| 125 | MP0005390_skeleton_phenotype | 0.79630066 |
| 126 | MP0000733_abnormal_muscle_development | 0.79509684 |
| 127 | MP0005451_abnormal_body_composition | 0.78439506 |
| 128 | MP0002971_abnormal_brown_adipose | 0.77831771 |
| 129 | MP0002168_other_aberrant_phenotype | 0.76608743 |
| 130 | MP0002128_abnormal_blood_circulation | 0.76418001 |
| 131 | MP0004043_abnormal_pH_regulation | 0.76217334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.50115018 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.50115018 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.50115018 |
| 4 | Hematochezia (HP:0002573) | 4.47112256 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.38161811 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.15836045 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.14418324 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.05830025 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.75850559 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.71069052 |
| 11 | Glomerulonephritis (HP:0000099) | 3.52700941 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.47372496 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.35485459 |
| 14 | Myocardial infarction (HP:0001658) | 3.32022083 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.22515717 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.16819910 |
| 17 | Complement deficiency (HP:0004431) | 3.14042084 |
| 18 | Axonal loss (HP:0003447) | 3.08167854 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.90559794 |
| 20 | Esophageal varix (HP:0002040) | 2.89001961 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.75125688 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 2.75125688 |
| 23 | Mitral stenosis (HP:0001718) | 2.73690407 |
| 24 | Aortic aneurysm (HP:0004942) | 2.71656035 |
| 25 | Polycythemia (HP:0001901) | 2.63730480 |
| 26 | Nephritis (HP:0000123) | 2.59643641 |
| 27 | Recurrent skin infections (HP:0001581) | 2.59481834 |
| 28 | Papillary thyroid carcinoma (HP:0002895) | 2.58314654 |
| 29 | Abnormality of the fingertips (HP:0001211) | 2.52451308 |
| 30 | Vascular tortuosity (HP:0004948) | 2.49859635 |
| 31 | Disinhibition (HP:0000734) | 2.49093313 |
| 32 | Gingival bleeding (HP:0000225) | 2.45873676 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.45239971 |
| 34 | Arterial tortuosity (HP:0005116) | 2.43960227 |
| 35 | Thick nail (HP:0001805) | 2.43452942 |
| 36 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.40326930 |
| 37 | Spondylolisthesis (HP:0003302) | 2.38294983 |
| 38 | Periodontitis (HP:0000704) | 2.33508002 |
| 39 | Gingivitis (HP:0000230) | 2.32081125 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.31289117 |
| 41 | Joint hemorrhage (HP:0005261) | 2.31286677 |
| 42 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29068158 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.27377111 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.26136131 |
| 45 | Portal hypertension (HP:0001409) | 2.25027292 |
| 46 | Abnormality of complement system (HP:0005339) | 2.24370143 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.17653334 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.16558035 |
| 49 | Colitis (HP:0002583) | 2.13433872 |
| 50 | Skin nodule (HP:0200036) | 2.08874239 |
| 51 | Epidermoid cyst (HP:0200040) | 2.08712244 |
| 52 | Retinal atrophy (HP:0001105) | 2.08540949 |
| 53 | Deep venous thrombosis (HP:0002625) | 2.08522074 |
| 54 | Tubulointerstitial fibrosis (HP:0005576) | 2.07902827 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.07734754 |
| 56 | Inappropriate behavior (HP:0000719) | 2.07264444 |
| 57 | Asymmetric septal hypertrophy (HP:0001670) | 2.05695217 |
| 58 | Abnormality of the hepatic vasculature (HP:0006707) | 2.05149404 |
| 59 | Conjunctival telangiectasia (HP:0000524) | 2.02048185 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.01252950 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01252950 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.01070560 |
| 63 | Optic neuritis (HP:0100653) | 2.01070560 |
| 64 | Arterial thrombosis (HP:0004420) | 1.99987757 |
| 65 | Metaphyseal dysplasia (HP:0100255) | 1.98870260 |
| 66 | Recurrent viral infections (HP:0004429) | 1.98366250 |
| 67 | Hyperventilation (HP:0002883) | 1.97391950 |
| 68 | Abnormality of the periventricular white matter (HP:0002518) | 1.97130600 |
| 69 | Prostate neoplasm (HP:0100787) | 1.95026362 |
| 70 | Fair hair (HP:0002286) | 1.92897270 |
| 71 | Aortic dissection (HP:0002647) | 1.91555330 |
| 72 | Hydroxyprolinuria (HP:0003080) | 1.91424040 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 1.91424040 |
| 74 | Progressive visual loss (HP:0000529) | 1.91035359 |
| 75 | Abnormality of the lumbar spine (HP:0100712) | 1.90707083 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90233167 |
| 77 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90233167 |
| 78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90233167 |
| 79 | Slow saccadic eye movements (HP:0000514) | 1.89357410 |
| 80 | Pulmonary embolism (HP:0002204) | 1.89134397 |
| 81 | Epistaxis (HP:0000421) | 1.88850480 |
| 82 | Orchitis (HP:0100796) | 1.88721854 |
| 83 | Keratoconjunctivitis (HP:0001096) | 1.88029536 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 1.87949503 |
| 85 | Cerebral aneurysm (HP:0004944) | 1.87714547 |
| 86 | Myositis (HP:0100614) | 1.87050486 |
| 87 | Xanthomatosis (HP:0000991) | 1.86169796 |
| 88 | Thyroid carcinoma (HP:0002890) | 1.85642314 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 1.84319122 |
| 90 | Hemorrhage of the eye (HP:0011885) | 1.84317552 |
| 91 | Facial diplegia (HP:0001349) | 1.84174231 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 1.83675587 |
| 93 | Abnormality of the common coagulation pathway (HP:0010990) | 1.83478021 |
| 94 | Protuberant abdomen (HP:0001538) | 1.82565776 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 1.82258010 |
| 96 | Pulmonary artery stenosis (HP:0004415) | 1.81694729 |
| 97 | Prolonged bleeding time (HP:0003010) | 1.81582747 |
| 98 | Cellulitis (HP:0100658) | 1.81124100 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81000433 |
| 100 | Cone-rod dystrophy (HP:0000548) | 1.80479211 |
| 101 | Macroorchidism (HP:0000053) | 1.79965129 |
| 102 | Widely spaced teeth (HP:0000687) | 1.77309054 |
| 103 | Disproportionate tall stature (HP:0001519) | 1.77120357 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 1.74938632 |
| 105 | Curly hair (HP:0002212) | 1.74440277 |
| 106 | Abnormality of chloride homeostasis (HP:0011422) | 1.74405263 |
| 107 | Pustule (HP:0200039) | 1.72787320 |
| 108 | Broad metatarsal (HP:0001783) | 1.72747212 |
| 109 | Tetraparesis (HP:0002273) | 1.71770291 |
| 110 | Inflammation of the large intestine (HP:0002037) | 1.71591068 |
| 111 | Metaphyseal irregularity (HP:0003025) | 1.68060571 |
| 112 | Vascular calcification (HP:0004934) | 1.67505235 |
| 113 | Poikilocytosis (HP:0004447) | 1.66653438 |
| 114 | Amyloidosis (HP:0011034) | 1.66259317 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.65963796 |
| 116 | Toxemia of pregnancy (HP:0100603) | 1.65895022 |
| 117 | Congenital sensorineural hearing impairment (HP:0008527) | 1.65726128 |
| 118 | Intrahepatic cholestasis (HP:0001406) | 1.65317267 |
| 119 | Thickened calvaria (HP:0002684) | 1.65081244 |
| 120 | Tubulointerstitial abnormality (HP:0001969) | 1.64897587 |
| 121 | Peripheral demyelination (HP:0011096) | 1.64656011 |
| 122 | Ovoid vertebral bodies (HP:0003300) | 1.64104145 |
| 123 | Cardiomegaly (HP:0001640) | 1.62560180 |
| 124 | Acute myeloid leukemia (HP:0004808) | 1.62517583 |
| 125 | Premature skin wrinkling (HP:0100678) | 1.62313619 |
| 126 | Increased CSF protein (HP:0002922) | 1.61957472 |
| 127 | Subacute progressive viral hepatitis (HP:0006572) | 1.61492784 |
| 128 | Syncope (HP:0001279) | 1.61477534 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 1.61056446 |
| 130 | Osteomyelitis (HP:0002754) | 1.60289667 |
| 131 | Peritonitis (HP:0002586) | 1.60183469 |
| 132 | Frequent falls (HP:0002359) | 1.59664494 |
| 133 | Cardiovascular calcification (HP:0011915) | 1.59353709 |
| 134 | Hepatocellular carcinoma (HP:0001402) | 1.59105289 |
| 135 | Coarse hair (HP:0002208) | 1.58708527 |
| 136 | Mutism (HP:0002300) | 1.58031103 |
| 137 | Loss of speech (HP:0002371) | 1.57519615 |
| 138 | Spinal muscular atrophy (HP:0007269) | 1.57510001 |
| 139 | Urticaria (HP:0001025) | 1.57371774 |
| 140 | Depressed nasal tip (HP:0000437) | 1.56424711 |
| 141 | Mitral valve prolapse (HP:0001634) | 1.56127381 |
| 142 | Hypoalphalipoproteinemia (HP:0003233) | 1.55292686 |
| 143 | Cerebral hemorrhage (HP:0001342) | 1.54592649 |
| 144 | Thrombophlebitis (HP:0004418) | 1.53852768 |
| 145 | Absent frontal sinuses (HP:0002688) | 1.53455951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.94062355 |
| 2 | ACVR1B | 3.64895849 |
| 3 | EPHB1 | 2.83318220 |
| 4 | MAP3K14 | 2.72495344 |
| 5 | TIE1 | 2.49202068 |
| 6 | TYK2 | 2.41490682 |
| 7 | TAOK3 | 2.37594270 |
| 8 | CAMKK2 | 2.02696421 |
| 9 | IRAK4 | 2.02195227 |
| 10 | IRAK3 | 1.97180339 |
| 11 | LATS1 | 1.94989101 |
| 12 | EPHA3 | 1.85057659 |
| 13 | ERN1 | 1.84681165 |
| 14 | MAP3K2 | 1.82965812 |
| 15 | IKBKE | 1.80365688 |
| 16 | NUAK1 | 1.79866992 |
| 17 | CAMK1D | 1.78271886 |
| 18 | KIT | 1.76865488 |
| 19 | AKT3 | 1.75641112 |
| 20 | JAK1 | 1.70948640 |
| 21 | TRPM7 | 1.64455318 |
| 22 | FER | 1.61297643 |
| 23 | PTK2B | 1.60082850 |
| 24 | PDK2 | 1.58054712 |
| 25 | YES1 | 1.57616497 |
| 26 | FRK | 1.55960917 |
| 27 | MAP2K3 | 1.52319842 |
| 28 | TBK1 | 1.51356052 |
| 29 | STK3 | 1.50687695 |
| 30 | FGFR3 | 1.49851722 |
| 31 | NEK9 | 1.49762685 |
| 32 | INSRR | 1.45606287 |
| 33 | IRAK1 | 1.45377721 |
| 34 | PTK6 | 1.43634018 |
| 35 | MAP3K3 | 1.42458877 |
| 36 | CDK6 | 1.39278925 |
| 37 | GRK7 | 1.32772882 |
| 38 | KDR | 1.32369201 |
| 39 | CAMK1G | 1.32366677 |
| 40 | CSK | 1.30873667 |
| 41 | JAK3 | 1.26127845 |
| 42 | ERBB3 | 1.24662649 |
| 43 | STK10 | 1.23592946 |
| 44 | IKBKB | 1.23045301 |
| 45 | CSF1R | 1.20049004 |
| 46 | ITK | 1.19046484 |
| 47 | MATK | 1.19014398 |
| 48 | CHUK | 1.18904088 |
| 49 | RIPK1 | 1.18251083 |
| 50 | FGFR4 | 1.17595265 |
| 51 | BMPR2 | 1.16009352 |
| 52 | TEC | 1.14732644 |
| 53 | MAPK15 | 1.14555682 |
| 54 | PDGFRB | 1.08811460 |
| 55 | FGFR2 | 1.08712224 |
| 56 | PINK1 | 1.06382244 |
| 57 | JAK2 | 1.04634674 |
| 58 | MST4 | 0.99268332 |
| 59 | CDK12 | 0.95206181 |
| 60 | STK39 | 0.94498464 |
| 61 | PRKAA2 | 0.91723804 |
| 62 | DDR2 | 0.91403518 |
| 63 | SGK3 | 0.90180073 |
| 64 | MET | 0.87030870 |
| 65 | STK4 | 0.86870469 |
| 66 | RIPK4 | 0.86336624 |
| 67 | SIK1 | 0.86045249 |
| 68 | KSR1 | 0.85738399 |
| 69 | STK38L | 0.85230964 |
| 70 | HCK | 0.82337499 |
| 71 | GSK3A | 0.82269839 |
| 72 | MAP4K1 | 0.81590277 |
| 73 | NLK | 0.81497888 |
| 74 | DMPK | 0.81257224 |
| 75 | CDK9 | 0.80666787 |
| 76 | WNK1 | 0.80643392 |
| 77 | BMPR1B | 0.80218983 |
| 78 | BTK | 0.78331191 |
| 79 | PIM1 | 0.78276084 |
| 80 | TTN | 0.78263066 |
| 81 | MYLK | 0.76655859 |
| 82 | CLK1 | 0.75923816 |
| 83 | MAP3K13 | 0.75327697 |
| 84 | STK11 | 0.74957270 |
| 85 | BLK | 0.74873806 |
| 86 | HIPK2 | 0.74445754 |
| 87 | OXSR1 | 0.73956869 |
| 88 | EGFR | 0.71252195 |
| 89 | WNK4 | 0.70853986 |
| 90 | PIK3CA | 0.70777202 |
| 91 | CCNB1 | 0.69633842 |
| 92 | PIK3CG | 0.69107852 |
| 93 | DAPK2 | 0.67506517 |
| 94 | PDGFRA | 0.66872446 |
| 95 | BRSK2 | 0.66778149 |
| 96 | SGK2 | 0.65597950 |
| 97 | MAPK7 | 0.64116735 |
| 98 | ABL1 | 0.63966681 |
| 99 | LCK | 0.63899509 |
| 100 | MAP3K12 | 0.63884233 |
| 101 | IGF1R | 0.62938275 |
| 102 | RET | 0.62536277 |
| 103 | MELK | 0.62184956 |
| 104 | IRAK2 | 0.61856551 |
| 105 | ZAP70 | 0.61722022 |
| 106 | NEK6 | 0.60799384 |
| 107 | CAMK4 | 0.59991897 |
| 108 | PDPK1 | 0.59168999 |
| 109 | MAP3K7 | 0.58809430 |
| 110 | FGR | 0.58709047 |
| 111 | MARK3 | 0.58022771 |
| 112 | MAP2K1 | 0.57576272 |
| 113 | DYRK1B | 0.56086781 |
| 114 | ADRBK2 | 0.56008180 |
| 115 | STK24 | 0.55572951 |
| 116 | PRKCH | 0.55234204 |
| 117 | MST1R | 0.54134518 |
| 118 | PRKCE | 0.53374793 |
| 119 | PAK3 | 0.53334376 |
| 120 | PTK2 | 0.53309556 |
| 121 | PLK2 | 0.52177691 |
| 122 | PBK | 0.52155496 |
| 123 | PRKG2 | 0.51775956 |
| 124 | PDK1 | 0.51331289 |
| 125 | BMX | 0.51031754 |
| 126 | PRKCQ | 0.50815065 |
| 127 | STK38 | 0.50583170 |
| 128 | LYN | 0.50246802 |
| 129 | MAPKAPK5 | 0.48325704 |
| 130 | MAP3K1 | 0.48263699 |
| 131 | MAPK12 | 0.47770794 |
| 132 | SGK223 | 0.46881875 |
| 133 | SGK494 | 0.46881875 |
| 134 | ADRBK1 | 0.46176182 |
| 135 | TGFBR1 | 0.45350886 |
| 136 | PRKD1 | 0.44761171 |
| 137 | MAP3K6 | 0.43971928 |
| 138 | TXK | 0.41840696 |
| 139 | MUSK | 0.40046717 |
| 140 | PAK2 | 0.39341560 |
| 141 | ERBB2 | 0.38300276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.88057500 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96552427 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89786635 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84066772 |
| 5 | Malaria_Homo sapiens_hsa05144 | 1.66276248 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65831523 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 1.62399230 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54809583 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49113693 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.48555660 |
| 11 | ABC transporters_Homo sapiens_hsa02010 | 1.46103376 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45260259 |
| 13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43522819 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42274185 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.38667551 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36879310 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36774901 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36352051 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36234643 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19721498 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19066531 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16205096 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15515049 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14615438 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.12090590 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.11886337 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11575780 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09413055 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08639705 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04750838 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04654726 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04481823 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.03032835 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.02645894 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.01814572 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01701104 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.00670774 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99534807 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.99112420 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98873408 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98712082 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 0.98372488 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 0.98249803 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94240946 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93698898 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91931092 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91914140 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90768328 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87736581 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87591805 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.87361064 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85662055 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85123763 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 0.84431360 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84101309 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82169588 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81350312 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81296554 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79333077 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78310877 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77785324 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.75780581 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75158666 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75131013 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74378438 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74338985 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74227361 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74024204 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.73520907 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72865662 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72760832 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72564098 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.72229144 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.72133643 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71758453 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71337792 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.70936944 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.70906301 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70382668 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69685088 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.69525383 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69406236 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68598149 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68424027 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.68241920 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67820990 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.67819164 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67682017 |
| 89 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67250120 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.66265108 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65970376 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63961904 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.61878045 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61875125 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61532879 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60971001 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60353262 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59929078 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58537916 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58338086 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58183135 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58014686 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57895788 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57462236 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57051557 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56438372 |
| 107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56436807 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55398483 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.55053257 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55024788 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.54875860 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54219944 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54214003 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53340192 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53262720 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52897469 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52453429 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52350891 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52246175 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52181005 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50894232 |
| 122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50860296 |
| 123 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50779571 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49994879 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49306523 |
| 126 | Asthma_Homo sapiens_hsa05310 | 0.48296983 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48167337 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46914009 |

